Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Ranked against 8 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZS | $38.8B | — | — | 11.6× | 25.4% | 76.8% | -1.9% | -2.4% | -2.4% | — | 232 |
| CTSH | $29.1B | 14.3× | 7.0× | 1.4× | 7.0% | — | 10.6% | 14.9% | 14.3% | -0.3× | 242 |
| EPAM | $7.2B | 20.9× | 10.4× | 1.3× | 15.4% | 28.8% | 6.9% | 10.3% | 10.2% | -2.2× | 107 |
| DOX | $6.6B | 14.8× | 9.1× | 1.3× | 2.4% | 35.1% | 9.9% | 14.3% | 12.0% | 0.4× | 101 |
| DOCS | $5.8B | 33.4× | 24.5× | 9.1× | 13.1% | 89.1% | 30.4% | 20.6% | 20.6% | -1.0× | 78 |
| MGRT | $1.6B | — | — | — | 233% | 50.7% | 16.1% | 11.5% | 11.0% | -0.1× | 1 |
| ISSC | $444M | 28.2× | 19.5× | 5.3× | 78.6% | 48.1% | 18.5% | 24.2% | 17.6% | 0.9× | 19 |
| PERI | $359M | — | 97.1× | 0.8× | -11.7% | — | -1.8% | -1.2% | -1.2% | — | 11 |
| RDNW | $197M | — | 42.6× | 0.2× | -10.5% | 27.5% | -4.8% | 419% | -26.9% | — | 8 |
Peers = companies sharing MGRT's sector (Services-Computer Programming Services) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 3 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 11%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 3 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $11.1M 100.0% | $3.3M 100.0% | $3.2M 100.0% |
| Cost of Revenue | $5.5M 49.3% | $1.5M 46.1% | $2.0M 60.7% |
| Gross Profit | $5.6M 50.7% | $1.8M 53.9% | $1.3M 39.3% |
| Selling, General & Admin | $1.8M 16.5% | $1.1M 33.0% | $514K 15.8% |
| Total Operating Expenses | $3.4M 30.4% | $1.2M 37.5% | $722K 22.2% |
| Operating Income | $2.2M 20.3% | $545K 16.4% | $553K 17.0% |
| Interest Expense | $20K 0.2% | $20K 0.6% | $21K 0.7% |
| Other Income (Expense), net | $71K 0.6% | $31K 0.9% | $65K 2.0% |
| Pretax Income | $2.3M 20.9% | $576K 17.3% | $618K 19.0% |
| Income Tax Expense | $532K 4.8% | $174K 5.2% | $81K 2.5% |
| Net Income | $1.8M 16.1% | $402K 12.1% | $537K 16.5% |
| Per Share | |||
| EPS (Basic) | $0.17 | $0.04 | $0.05 |
| EPS (Diluted) | $0.17 | $0.04 | $0.05 |
| Weighted Avg Shares (Basic) | 10.8M | 10.0M | 10.0M |
| Weighted Avg Shares (Diluted) | 10.8M | 10.0M | 10.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $765K covers all $662K of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2025-09-30 (20-F).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~3.0% on $662K of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow on any basis, so a reverse DCF can't be run.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 2 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-10-30
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 11% against ROIC 11% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 21.1% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.3× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cost of Revenue | 60.7 | 46.1 | 49.3 |
| Gross Profit | 39.3 | 53.9 | 50.7 |
| SG&A | 15.8 | 33.0 | 16.5 |
| Operating Income | 17.0 | 16.4 | 20.3 |
| Income Tax | 2.5 | 5.2 | 4.8 |
| Net Income | 16.5 | 12.1 | 16.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MGRT: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns 0.9pts above its cost of capital, without much margin of safety.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2023 | 45.2% | 10.2% (today's — no rate published for this year) | 35.0pts |
| FY2024 | 36.8% | 9.5% | 27.3pts |
| FY2025 | 11.1% | 9.4% | 1.7pts |
| Now | 11.0% | 10.2% | 0.8pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2023 | 39.3% | 17.0% | 16.5% |
| FY2024 | 53.9% | 16.4% | 12.1% |
| FY2025 | 50.7% | 20.3% | 16.1% |
Return on equity (11%) and return on invested capital (11%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
The spread is 0.9pts and would invert under a ±2% move in WACC, so the verdict rests on the cost-of-capital assumption rather than on the business.
Fewer than three profitable years with a cash flow statement, so cash conversion cannot be judged.
No material counter-signal in the checked set: FCF / net income over 3 and 5 years, Sloan accruals, SBC as a share of revenue, SBC as a share of operating cash flow, SBC-adjusted free cash flow, free cash flow per diluted share, buybacks against SBC issued, capex vs depreciation, free cash flow against revenue, share count since the first year on file, cash conversion cycle (DSO, DIO, DPO), receivables growth against revenue growth.
Missing from our data, so excluded from this answer: 3 years of cash flow.
Covers interest 78.1x even after a 30% EBITDA decline.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 111.53x |
| 5% | 105.95x |
| 10% | 100.38x |
| 15% | 94.80x |
| 20% | 89.22x |
| 25% | 83.65x |
| 30% | 78.07x |
| 35% | 72.49x |
| 40% | 66.92x |
| 45% | 61.34x |
| 50% | 55.76x |
| 55% | 50.19x |
| 60% | 44.61x |
Ladder as of 2025-09-30 (20-F); cash from the 2025-09-30 balance sheet; FCF from FY2025.
Balance sheet at 2025-09-30. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
No positive free cash flow to discount, so the price cannot be expressed as a growth requirement.
No material counter-signal in the checked set: reverse-DCF implied growth, historical FCF CAGR, per-year FCF growth distribution, reporting-basis breaks, discount rate used, free-cash-flow basis (stock comp charged?).
Missing from our data, so excluded from this answer: free_cash_flow.